Dong Cen
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Nanoplatforms for cancer theranostics 15
-
- RNA Interference and Gene Delivery 2
- Fibroblast Growth Factor Research 2
- Co-authors
- Xiujun Cai (15 shared papers)Xiang Li (13 shared papers)Yifan Wang (8 shared papers)Gaorong Han (7 shared papers)Congkun Xie (3 shared papers)Yongjun Wu (4 shared papers)Junjie Xu (4 shared papers)Lin Ji (3 shared papers)
- Journals
- PLoS ONE (2 papers)Journal of Materials Chemistry B (2 papers)Advanced Science (2 papers)Cell Death and Disease (2 papers)Nano Research (2 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Dong Cen
34 papers receiving 1.2k citations
Dong Cen's Hit Papers
Peers
Comparison fields: 5 of 88
- Cancer Research 266
- Biomaterials 173
- Biomedical Engineering 501
- Biochemistry 60
- Molecular Biology 489
Countries citing papers authored by Dong Cen
This map shows the geographic impact of Dong Cen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dong Cen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dong Cen more than expected).
Fields of papers citing papers by Dong Cen
This network shows the impact of papers produced by Dong Cen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dong Cen. The network helps show where Dong Cen may publish in the future.
Co-authors
The 25 scholars most cited alongside Dong Cen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 222 | |
| 2 | ZnS@BSA Nanoclusters Potentiate Efficacy of Cancer Immunotherapy Hit paper breakdown → | 2021 | 195 |
| 3 | 2020 | 161 | |
| 4 | 2018 | 85 | |
| 5 | 2020 | 85 | |
| 6 | 2020 | 71 | |
| 7 | 2019 | 69 | |
| 8 | 2023 | 54 | |
| 9 | 2021 | 23 | |
| 10 | 2018 | 19 | |
| 11 | 2017 | 19 | |
| 12 | 2020 | 19 | |
| 13 | 2016 | 16 | |
| 14 | 2019 | 16 | |
| 15 | 2020 | 14 | |
| 16 | 2020 | 13 | |
| 17 | 2020 | 12 | |
| 18 | 2018 | 12 | |
| 19 | 2018 | 11 | |
| 20 | 2009 | 9 |
About Dong Cen
Dong Cen is a scholar working on Biomedical Engineering, Molecular Biology, Materials Chemistry, Immunology and Pulmonary and Respiratory Medicine, having authored 37 papers that have together received 1.2k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (15 papers), Nanoparticle-Based Drug Delivery (4 papers), Advanced Nanomaterials in Catalysis (4 papers), Photodynamic Therapy Research Studies (3 papers), Sulfur Compounds in Biology (3 papers), RNA Interference and Gene Delivery (2 papers), Immune cells in cancer (2 papers) and Fibroblast Growth Factor Research (2 papers). The work is most often cited by research in Cancer Research (266 citations), Biomaterials (173 citations), Biomedical Engineering (501 citations), Biochemistry (60 citations) and Molecular Biology (489 citations). Dong Cen has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Xiujun Cai, Xiang Li, Yifan Wang, Gaorong Han, Congkun Xie, Yongjun Wu, Junjie Xu, Lin Ji, Zhaohui Ren and Zhe Wan. Their work appears in journals such as PLoS ONE, Journal of Materials Chemistry B, Advanced Science, Cell Death and Disease and Nano Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.